Qingdao Baheal Medical (SZSE:301015) ROCE % : 26.05% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Qingdao Baheal Medical ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Qingdao Baheal Medical's annualized ROCE % for the quarter that ended in Mar. 2024 was 26.05%.

Qingdao Baheal Medical ROCE % Historical Data

The historical data trend for Qingdao Baheal Medical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao Baheal Medical ROCE % Chart

Qingdao Baheal Medical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

29.04

30.41

33.49

31.40

31.64

Qingdao Baheal Medical Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															27.25	36.61	31.70	27.85	26.05

Qingdao Baheal Medical ROCE % Calculation

Qingdao Baheal Medical's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	934.265	/	( ( (5030.204 - 2603.807)	+	(5298.597 - 1818.88) )	/ 2 )
	=	934.265	/	( (2426.397	+	3479.717)	/ 2 )
	=	934.265	/	2953.057
	=	31.64 %

Qingdao Baheal Medical's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	929.028	/	( ( (5298.597 - 1818.88)	+	(5648.06 - 1996.463) )	/ 2 )
	=	929.028	/	( ( 3479.717	+	3651.597 )	/ 2 )
	=	929.028	/	3565.657
	=	26.05 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Qingdao Baheal Medical (SZSE:301015) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Qingdao Baheal Medical ROCE % Related Terms

Thank you for viewing the detailed overview of Qingdao Baheal Medical's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Qingdao Baheal Medical (SZSE:301015) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qingdao Baheal Medical Inc (SZSE:301015) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

No. 88 Kaifeng Road, Shibei District, Shandong Province, Qingdao, CHN, 266042

Website

http://www.baheal.cn

Qingdao Baheal Medical Inc is engaged in providing comprehensive marketing services for pharmaceutical product manufacturers.

Qingdao Baheal Medical (SZSE:301015) Headlines

No Headlines